Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
661.00    -4.00 (-0.60%)
Bid:
660.00
Ask:
662.00
Spread: 2.00 (0.303%)
Market Cap: £538.03m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

6 Jan 2009 08:41

RNS Number : 1619L
Bloomsbury Publishing PLC
06 January 2009
 



 

Bloomsbury Publishing Plc

("Bloomsbury")

Bloomsbury acquires Arden Shakespeare

Bloomsbury Publishing Plc is pleased to announce the acquisition of Arden Shakespeare from Cengage Learning. This transaction is not material to Bloomsbury.

  Arden Shakespeare is the most academically rigorous Shakespeare series in print, and the best-known English literature brand worldwide. Originally created by the British publishing firm of Methuen in the late nineteenth century, and edited by a distinguished collection of scholars, the series took 25 years to complete from the launch of the first title, Edward Dowden's Hamlet, in 1899. In 1995 the Third Series of The Arden Shakespeare was launched. Now published under the imprint Arden Shakespeare, under the General Editorship of Richard Proudfoot, Ann Thompson, David Scott Kastan and Henry Woudhuysen, the Arden Shakespeare Third Series is nearing completion. Each new volume supersedes the corresponding Second Series text, being meticulously edited from the original sources by a contemporary scholar.

Arden Shakespeare will retain its internationally recognised name and become part of the Methuen Drama imprint (acquired in 2006 by A&C Black which is a wholly owned subsidiary of Bloomsbury). The acquisition will make Methuen Drama Europe's largest performing arts list, which includes work by Bertolt Brecht, Oscar Wilde, Bernard Shaw and Arthur Miller as well as contemporary playwrights such as Michael Frayn and Willy Russell, Methuen Student editions and the New Mermaids critical editions.

'I am delighted that the Arden Shakespeare series is returning to MethuenArden is a highly prestigious addition to our performing arts publishing and fits perfectly with our strategy of acquiring high quality perennial publishing lists which have significant potential for digital exploitation. We look forward to working with the Arden General Editors Richard Proudfoot, Ann Thompson, David Scott Kastan and Henry Woudhuysen to grow and strengthen this important list' says A&C Black Managing Director, Jill Coleman.

Jill Jones, CEO Cengage Learning EMEA said, 'The Arden Shakespeare is an excellent fit for Bloomsbury: we wish A&C Black, all volume editors, authors and General Editors from the Arden Shakespeare success for the future'.

www.methuendrama.com

-ends-

For further enquiries:

Bloomsbury Publishing PLC

Jill Coleman, Bloomsbury Publishing Plc care of Bell Pottinger

Bell Pottinger Corporate & Financial

Ben Woodford / Rosanne Perry +44 (0)20 7861 3232

Notes to Editors

About Bloomsbury Publishing Plc 

(www.bloomsbury.com and www.bloomsbury-ir.co.uk)

Bloomsbury Publishing is one of the world's leading independentpublicly quoted publishing houses with a reputation for a high quality management team and a highly valuable portfolio of intellectual properties including the Encarta World English Dictionary, JK Rowling's Harry Potter, Margaret Atwood, John Irving, David Guterson and Ben Schott. Other databases include Who's Who, Whitaker's AlmanackReed's Nautical Almanac, Black's Medical Dictionary, the Macmillan English Dictionary for Advanced Learners of EnglishBusiness: The Ultimate Resource and RSPB Handbook of British Birds. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUNOWRKKRARRR
Date   Source Headline
13th Aug 20215:49 pmRNSDirector/PDMR Shareholdings - Correction
10th Aug 20213:07 pmRNSDirector/PDMR Shareholdings
3rd Aug 20211:15 pmRNSDirector/PDMR Shareholding
21st Jul 20214:52 pmRNSResults of the 2021 Annual General Meeting
21st Jul 20217:00 amRNSAGM Trading Update
15th Jul 20213:31 pmRNSAnnual General Meeting
22nd Jun 20214:09 pmRNSAnnual Financial Report
11th Jun 20214:00 pmRNSHolding(s) in Company
4th Jun 20217:00 amRNSInvestor Results Presentation
3rd Jun 202111:46 amRNSHolding(s) in Company
2nd Jun 202112:17 pmRNSAcquisition
2nd Jun 20217:00 amRNSAudited Preliminary Results
1st Jun 20217:00 amRNSCompletion of Acquisition
5th May 20219:00 amRNSNotice of Results
23rd Apr 20217:00 amRNSAcquisition
8th Apr 20214:35 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFurther Trading Update
10th Mar 20218:46 amRNSHolding(s) in Company
17th Feb 20214:18 pmRNSBlock Listing Six Monthly Return
29th Jan 202112:00 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSTrading Update
14th Dec 20207:00 amRNSBoard Appointment
27th Oct 20207:00 amRNSUnaudited Interim Results
13th Oct 20203:37 pmRNSHolding(s) in Company
4th Sep 202012:08 pmRNSSecond Price Monitoring Extn
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20206:14 pmRNSDirector/PDMR Shareholding
28th Aug 20201:05 pmRNSTotal Voting Rights
25th Aug 20205:54 pmRNSFinal dividend: bonus issue of new shares
10th Aug 20205:04 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSDirector/PDMR Shareholding
31st Jul 20201:58 pmRNSFinal dividend: bonus issue of new shares
30th Jul 20205:54 pmRNSDirector/PDMR Shareholding
21st Jul 20201:00 pmRNSResults of the 2020 Annual General Meeting
21st Jul 20207:00 amRNSAGM Trading Update
8th Jul 20204:35 pmRNSAnnual General Meeting
18th Jun 20202:00 pmRNSAnnual Financial Report
17th Jun 202012:07 pmRNSSecond Price Monitoring Extn
17th Jun 202012:02 pmRNSPrice Monitoring Extension
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
3rd Jun 202012:02 pmRNSPrice Monitoring Extension
26th May 20205:26 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 20207:00 amRNSUnaudited Preliminary Results
28th Apr 20203:37 pmRNSDisclosure of Rights Attached to Equity Shares
24th Apr 20209:10 amRNSHolding(s) in Company
24th Apr 20209:06 amRNSHolding(s) in Company
21st Apr 20208:45 amRNSTotal Voting Rights
20th Apr 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.